Dergiler / Dicle Tıp Dergisi / 2026 / Cilt: 46 Sayı: 1

Alternative methods for the diagnosis of macroprolactinemia: urine prolactin level and serum / urine prolactin ratio

Sayfa
119–124
Yayın Tarihi
2019-03-03
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

ROC analysis(control-macroprolactin) for serum/urine prolactin ratio (Sensitivity 84.6 specificity 93.7 cut off >549,5 AUC=0.83) p<0.01 Conclusion: Urinary prolactin level and serum/urine prolactin ratio may be used in diagnosis of macroprolactinemia.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of this study was to investigate the urine prolactin and serum/urine prolactin ratio for accuracy diagnosis of macroprolactinemia.
📊
Temel Bulgular & Veri:Results: A total of 41 patients were included in the study.
💡
Sonuç & Katkı:ROC analysis(control-macroprolactin) for serum/urine prolactin ratio (Sensitivity 84.6 specificity 93.7 cut off >549,5 AUC=0.83) p<0.01 Conclusion: Urinary prolactin level and serum/urine prolactin ratio may be used in diagnosis of macroprolactinemia.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:macroprolactinemia · urine prolactin

Özet

Objective: The aim of this study was to investigate the urine prolactin and serum/urine prolactin ratio for accuracy diagnosis of macroprolactinemia. Methods: In the retrospective cross-sectional analysis, prolactin levels (high or normal) in the reproductive period of men and women were included in the study. Polyethylene glycol (PEG) precipitation method was used for the detection of macroprolactinemia. Then, patients were divided into three groups as macroprolactinemia, prolactinoma and healthy control group. In patients, prolactin values in spot urine with simultaneous serum prolactin values were calculated. The non-parametric Kruskal-Wallis test was used to compare the groups. The receiver-operating characteristic (ROC) curve was determined to evaluate the predictive power of serum/urine prolactin ratio. Results: A total of 41 patients were included in the study. Female/male:36 (87.8%)/ 5 (12.2%). Urinary prolactin median(minimum-maximum) values were macroprolactinemia, prolactinoma and control group, respectively; 0.06(0.05-0.10), 0.11(0.02-0.95), 0.08(0.05-0.25) ng/ml. Serum/urine ratio median (minium-maximum) values were macroprolactinemia, prolactinoma, and control group, respectively; 633(51-1032), 990(104-9635), 395.5(138-953). When the groups were compared, the patients with prolactinoma had higher urinary prolactin levels(p <0.01). Serum/urine prolactin ratio was found to be the highest in prolactinoma patients and the lowest in the control group and a significant difference was observed in groups (p <0.01). ROC analysis(control-macroprolactin) for serum/urine prolactin ratio (Sensitivity 84.6 specificity 93.7 cut off >549,5 AUC=0.83) p<0.01 Conclusion: Urinary prolactin level and serum/urine prolactin ratio may be used in diagnosis of macroprolactinemia.

🔖

Bu Makaleye Atıf Yap

Pekkolay, Z., Tuna, M. M., Güven, M., Tuzcu, Ş. A., Kaplan, İ., Akkuş, Z., Tuzcu, A. K. (2019). Alternative methods for the diagnosis of macroprolactinemia: urine prolactin level and serum / urine prolactin ratio. Dicle Tıp Dergisi, Cilt: 46 Sayı: 1, 119–124. https://doi.org/10.5798/dicletip.534848

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (18)

  1. Horseman ND and Gregerson KA. Prolactin actions. Journal of Molecular Endocrinology. 2014; 52: 95-106.
  2. Melmed S, Casanueva FF, Hoffman AR, et all. Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 273-88.
  3. Freeman ME, Kanyicska B, Lerant A, et all. Prolactin: structure, function, and regulation of secretion. Physiological Reviews. 2000; 80: 1523–631.
  4. Molitch ME. Prolactin in human reproduction In: Strauss JF, Barbieri R, eds. Yen and Jaffe's reproductive endocrinology: physiology, pathophysiology, and clinical management, 7th edn. Elsevier Saunders, Philadelphia 2014: 45-65.
  5. Hattori N, Ishihara T, Saiki Y, et all. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. Clin Endocrinol (Oxf). 2010; 73: 792–7.
  6. Hattori N, Nakayama Y, Kitagawa K, et all. Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia. Clin Endocrinol (Oxf). 2006; 190: 287-93.
  7. Freeman ME, Kanyicska B, Lerant A, et all. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80:1523–631.
  8. Samson SL, Hamrahian AH, Ezzat S. American Association of Clinical Endocrinologists. American College of Endocrinology disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia. Endocr Pract. 2015; 21: 1427–35.
  9. Hattori N, Ishihara T, Saiki Y, et all. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. Clinical Endocrinology. 2010; 73: 792–7.
  10. Jamaluddin FA, Sthaneshwar P, Hussein Z, et all. Importance of screening for macroprolactin in all hyperprolactinaemic sera. Malays J Patho. 2013; 35: 59–63.
  11. Leslie H, Courtney CH, Bell PM, et all. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab. 2001; 86: 2743-6.
  12. Silva AM, Costa da PM, Pacheco A, et all. Assessment of macroprolactinemia by polyethylene glycol precipitation method. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo 2014; 9: 25-28.
  13. Snyder PJ, Causes of hyperprolactinemia. https://www.uptodate.com/contents/causes of hyperprolactinemia.
  14. Smith TP, Kavanagh L, Healy ML, et all. Technology insight: measuring prolactin in clinical samples. Nature Reviews Endocrinology. 2007; 3: 279-89.
  15. Coppedge RL, Segaloff A. Urinary Prolactin Excretion In Man, The Journal Of Clinical Endocrinology & Metabolism. 1951; 11: 465–76.
  16. Leaños-Miranda A, Márquez-Acosta J, Cárdenas-Mondragón GM, et all. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab. 2008; 93: 2492-9.
  17. Keely EJ, Charles F. Measurement of human urinary prolactin as a noninvasive study tool. Clinical chemistry. 1994; 40: 2017-21.
  18. Coppedge RL, Segaloff A. Urinary Prolactin Excretion In Man, The Journal Of Clinical Endocrinology & Metabolism. 1951; 11: 465–76.